InvestorsHub Logo
Followers 0
Posts 191
Boards Moderated 0
Alias Born 07/16/2005

Re: gaboy47 post# 23843

Friday, 10/23/2009 10:03:34 PM

Friday, October 23, 2009 10:03:34 PM

Post# of 30387
Gaboy,
I agree with you more than you realize. I am suspicious of people's motivations as well. I was once extremely hopeful for Recaf and this stock. I was so bullish that I allowed myself to get too heavily invested in this one stock. As the share price dropped, I stayed too long and lost too much. Sure, I could have held on and would still be waiting to recoop my initial investment. I think my average share price was in the .60's.

During the time that I was extremely bullish, I was like you and felt I was needing to help Dr. Moro get the word out about BOCX. I e-mailed cancer organizations and support groups. I put messages on the Abbott and Dendreon message boards. I did what I could. Dr. Moro was making advancements with the technology and test formats, but nothing ever seemed to get any traction. I eventually got frustrated with the lack of tangible results from Dr. Moro's hopeful PR's. While I owned the stock, I think I let hope for success cloud my judgement and not see the negatives. Now I see the positives and negatives and I admit that I don't know which way it will turn out. I recently bought back a few shares just in case Inverness makes the milestone payment.

I hope Dr. Moro is able to raise the funds needed. I do wonder why Dr. Moro would try to raise enough money for two years operations and create huge dilution at this share price. Why not raise enough money to pay off Smithline and operate for a short time. If Inverness makes the milestone payment, the share price should get a boost, Smithline would be out of our hair and, I would think that Dr. Moro could then easily place shares at a higher price. Is Dr. Moro thinking that revenues from oncopet and any progress from Inverness is still more than a year away?

mcd

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.